Pediatrics: Clinical Trials

7 trials for Pediatrics, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed. 7 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 37Completed 7

Follow Pediatrics: new trials by email Literature Review of Pediatrics trials Research Report on Pediatrics

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Norepinephrine for Prevention of Intraoperative Hypotension in Infants Undergoing Kasai Portoenterostomy
Norepinephrine Bitartrate, Placebo - Anesthesia, Pediatrics
Phase 3CompletedKasr El Aini Hospital312022-08-282024-07-09
The Hemodynamic Effects of Different Volumes of Bupivacaine 0.25% Caudal Blocks in Pediatrics Undergoing Lower Abdominal Surgeries as Measured by Electrical Cardiometry
Bupivacaine Hydrochloride - Anesthesia, Caudal, Pediatrics
Phase 3CompletedKasr El Aini Hospital1052021-11-152024-07-09
BOTOX® Open-Label Treatment in Pediatric Lower Limb Spasticity
Botulinum Toxin Type A - Pediatrics, Muscle Spasticity
Phase 3CompletedAllergan3702012-11-052019-08-21
BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity
Botulinum Toxin Type A - Pediatrics, Muscle Spasticity
Phase 3CompletedAllergan2202012-10-302019-08-21
BOTOX® Treatment in Pediatric Lower Limb Spasticity
botulinum toxin Type A, Normal Saline (Placebo) - Pediatrics, Muscle Spasticity
Phase 3CompletedAllergan3842012-09-112018-08-14
BOTOX® Treatment in Pediatric Upper Limb Spasticity
botulinum toxin Type A, Normal Saline (Placebo) - Pediatrics, Muscle Spasticity
Phase 3CompletedAllergan2352012-07-122018-08-14
Use of Dexmedetomidine to Reduce Emergence Delirium Incident in Children
Dexmedetomidine, Saline - Agitation, Anesthesia
Phase 3CompletedSt. Luke's-Roosevelt Hospital Center332009-08-012018-11-27

Narrower conditions

Cerebral Palsy (4)  ·  Muscle Spasticity (4)  ·  Stroke (2)  ·  Biliary Atresia (1)  ·  Emergence Delirium (1)  ·  Hypotension (1)  ·  Psychomotor Agitation (1)

Broader conditions

Nervous System Diseases (5)  ·  Neurologic Manifestations (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Signs and Symptoms (5)  ·  Brain Damage, Chronic (4)  ·  Brain Diseases (4)  ·  Central Nervous System Diseases (4)  ·  Muscle Hypertonia (4)  ·  Muscular Diseases (4)  ·  Musculoskeletal Diseases (4)  ·  Neuromuscular Manifestations (4)  ·  Cardiovascular Diseases (3)  ·  Vascular Diseases (3)  ·  Cerebrovascular Disorders (2)  ·  Aberrant Motor Behavior in Dementia (1)

Interventions

Botulinum Toxins, Type A (4)  ·  Saline Solution (2)  ·  Bupivacaine (1)  ·  Dexmedetomidine (1)  ·  Norepinephrine (1)  ·  Sodium Chloride (1)

Sponsors

Allergan (4)  ·  Kasr El Aini Hospital (2)  ·  St. Luke's-Roosevelt Hospital Center (1)

Countries

United States (5)  ·  Hungary (4)  ·  Philippines (4)  ·  Poland (4)  ·  Russia (4)  ·  South Korea (4)  ·  Thailand (4)  ·  Turkey (Türkiye) (4)  ·  Canada (2)  ·  Egypt (2)  ·  Italy (2)

Top investigators

Emily McCusker (2)  ·  Rozalina Dimitrova (2)  ·  Jolie Narang, M.D. (1)  ·  Khaled Sarhan, MD (1)

Results publications

PMID 40250622